Tonix Pharmaceuticals Holding Corp.
TNXP
$17.82
$0.633.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.08% | 49.19% | -177.81% | 54.74% | 13.76% |
| Total Depreciation and Amortization | -35.16% | -47.85% | 4.99% | 8.85% | 79.31% |
| Total Amortization of Deferred Charges | -15.97% | -12.18% | -- | -- | -- |
| Total Other Non-Cash Items | -89.10% | -30.01% | 2,552.45% | -290.16% | 23.64% |
| Change in Net Operating Assets | 1,667.49% | -544.33% | 182.81% | 132.42% | -93.77% |
| Cash from Operations | 34.51% | 19.60% | 57.55% | 46.60% | -0.17% |
| Capital Expenditure | 99.32% | 99.50% | 100.00% | 97.16% | 90.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.30% | 98.90% | 100.00% | 97.16% | 90.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 700.53% | 554.97% | 1,067.51% | -99.10% | 11.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -115.97% | -208.26% | -12,966.67% | -- | 394.83% |
| Cash from Financing | 109.15% | 583.85% | 582.70% | 98.16% | 463.20% |
| Foreign Exchange rate Adjustments | 340.00% | -41.67% | -- | 90.70% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 293.38% | 234.18% | 93.76% | 62.91% | 190.81% |